CALABRO', Luana

CALABRO', Luana  

Dipartimento di Medicina Traslazionale e per la Romagna  

Mostra records
Risultati 1 - 20 di 99 (tempo di esecuzione: 0.03 secondi).
Titolo Data di pubblicazione Autore(i) File
"Cancer Bio-Immunotherapy in Siena": Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8-10, 2015 2016 Maio, M; Bertocci, E; Fazio, C; Chiarucci, C; Cutaia, O; Scala, E; Giacobini, G; Lofiego, Mf; Fon...satti, E; Maccalli, C; Nicolay, Hj; Parmiani, G; Nibit, ; and collaborators (Anichini, A; Di Giacomo, Am; Sica, A; Calcinotto, A; Seliger, B; Buccione, C; Garlanda, C; Martinoli, C; Pozzi, C; Huber, C; Chartash, E; Carbone, E; Marincola, Fm; Zuccolotto, G; Schuler, G; Oliveira, G; Corna, G; Rammensee, Hg; Cuillerot, Jm; Rivoltini, L; Moretta, L; Calabro', L; Tagliamonte, M; Figini, M; Squadrito, Ml; Colombo, Mp; Giordano, M; Azab, M; Nistico', P; Thor Straten, P; Coulie, P; Ibrahim, R; Huber, S; Monfardini, S; Ferrone, S; Sahin, U; Bronte, V; Fridman, Wh; Trajanoski Z., ) file con accesso da definire
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation 2021 Maio, M; Lahn, M; Di Giacomo, Am; Covre, A; Calabro', L; Ibrahim, R; Fox, B; The Siena Think, Tank
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial 2022 L Kindler, Hedy; Novello, Silvia; Bearz, Alessandra; L Ceresoli, Giovanni; V Aerts, Joachim G J; ...Spicer, James; Taylor, Paul; Nackaerts, Kristiaan; Greystoke, Alastair; Jennens, Ross; Calabro', Luana; A Burgers, Jacobus; Santoro, Armando; Cedrés, Susana; Serwatowski, Piotr; Ponce, Santiago; P Van Meerbeeck, Jan; K Nowak, Anna; Blumenschein Jr, George; M Siegel, Jonathan; Kasten, Linda; Köchert, Karl; O Walter, Annette; H Childs, Barrett; Elbi, Cem; Hassan, Raffit; A Fennell, Dean
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25 2015 Hannani, D; Vétizou, M; Enot, D; Rusakiewicz, S; Chaput, N; Klatzmann, D; Desbois, M; Jacquelot, ...N; Vimond, N; Chouaib, S; Mateus, C; Allison, Jp; Ribas, A; Wolchok, Jd; Yuan, J; Wong, P; Postow, M; Mackiewicz, A; Mackiewicz, J; Schadendorff, D; Jaeger, D; Zörnig, I; Hassel, J; Korman, Aj; Bahjat, K; Maio, M; Calabro', L; Teng, Mw; Smyth, Mj; Eggermont, A; Robert, C; Kroemer, G; Zitvogel, L. file con accesso da definire
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study 2018 Barlesi, F; Vansteenkiste, J; Spigel, D; Ishii, H; Garassino, M; de Marinis, F; Özgüroğlu, M; Szc...zesna, A; Polychronis, A; Uslu, R; Krzakowski, M; Lee, J-S; Calabro', L; Frontera, Oa; Ellers-Lenz, B; Bajars, M; Ruisi, M; Park, R.
Avelumab Versus Docetaxel in Patients With Platinum-Treated Advanced NSCLC: 2-Year Follow-Up From the JAVELIN Lung 200 Phase 3 Trial 2021 Keunchil, Park; Mustafa, Özgüroglu; Johan, Vansteenkiste; David, Spigel; Yang, James C. H.; Hiden...obu, Ishii; Marina, Garassino; Filippo de Marinis, ; Aleksandra, Szczesna; Andreas, Polychronis; Ruchan, Uslu; Maciej, Krzakowski; Jong-Seok, Lee; Calabro', Luana; Osvaldo Arén Frontera, ; Huiling, Xiong; Marcis, Bajars; Mary, Ruisi; Fabrice, Barlesi
Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy 2021 Brilli, L.; Danielli, R.; Campanile, M.; Secchi, C.; Ciuoli, C.; Calabro', L.; Pilli, T.; Cartocc...i, A.; Pacini, F.; Di Giacomo, A. M.; Castagna, M. G.
Bioimmunotherapeutic targets on angiogenetic blood vessels in solid malignancies 2001 Maio, M; Altomonte, M; Calabro', L; Fonsatti, E
Biomarkers for immune checkpoint inhibitors--authors' reply 2014 Calabro', L; Maio, M.
Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer 2019 Landi, L; D’Inca', F; Gelibter, A; Chiari, R; Grossi, F; Delmonte, A; Passaro, A; Signorelli, D; ...Gelsomino, F; Galetta, D; Giannarelli, D; Soto Parra, H; Minuti, G; Tiseo, M; Migliorino, Mr; Cognetti, F; Toschi, L; Bidoli, P; Piantedosi, F; Calabro', L; Cappuzzo, F file con accesso da definire
Brief Communication PD1-related Nephrotoxicity: Optimizing Its Clinical Management Through Histopathologic Features 2022 Di Giacomo, Anna M.; Guarnieri, Andrea; Tripodi, Sergio A.; Maccari, Marta; Mancianti, Nicoletta;... Guido, Garosi; Rossi, Giulia; Daffinà, Maria Grazia; Calabro', Luana; Valente, Monica; Maio, Michele file con accesso da definire
Cancer Bio-Immunotherapy in Siena": Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17-19, 2013 2015 Calabro', Luana file con accesso da definire
Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9-11, 2014 2016 Maio, M; Bertocci, E; Pilla, L; Fazio, C; Chiarucci, C; Cutaia, O; Fonsatti, E; Maccalli, C; Parm...iani, G; Mondino, A; Robbins, Pf; Angelova, M; Stassi, G; Cioffi, M; Cavallo, F; Pellegatta, S; Sangiolo, D; Russo, V; Protti, Mp; Tripodo, C; Marchesi, F; Di Mitri, D; Ferrini, S; Bedognetti, D; Marincola, Fm; Fridman, Wh; Seliger, B; Cappuzzello, E; Moschella, F; Romero, P; Figdor, Cg; Griffiths, Ea; Aurisicchio, L; Weber, J; Calabro', L; Tumori, T; Ibrahim, R; Ferrè, P; Fabre, P; Del Vecchio, M; Tumori, N; Ramazzotti, M; Weide, B; Giannarelli, D; Elena, Tr; Guidoboni, M; Buonaguro, L; Tumori, Cd; Di Giacomo, Am. file con accesso da definire
Cancer bio‑immunotherapy XVI annual NIBIT‑(Italian Network for Tumor Biotherapy) meeting, October 11–13 2018, Milan, Italy 2020 Bellone, M; Brevi, A; Bruzzì, S; Consonni, M; De Santis, F; Di Lullo, G; Majorini, Mt; Pasto', A;... Amadori, A; Bregni, M; Di Nicola, M; Calabro', L; Ferrucci, Pf; Proietti, E; Colombo, Mp; Russo, V
CD40 expression by human melanocytic lesions and melanoma cell lines and direct CD40 targeting with the therapeutic anti-CD40 antibody CP-870.893 2010 Kabasi, A; Fonsatti, E; Natali, Pg; Altomonte, M; Bertocci, E; Cutaia, O; Calabro', L; Chiou, M; ...Tap, W; Chmielowski, B; Maio, M; Ribas, A
Challenges in lung cancer therapy during the COVID-19 pandemic 2020 Calabro', L; Peters, S; Soria, J-P; Di Giacomo, Am; Barlesi, F; Covre, A; Altomonte, M; Vegni, V;... Gridelli, C; Reck, M; Rizvi, N; Maio, M
Circulating haemopoietic and endothelial cells are decreased in COPD 2006 Palange, P; Testa, U; Huertas, A; Calabro', L; Antonucci, R; Pelosi, E; Pasquini, L; Satta, A; Mo...nici, G; Vignola, Ma; Monsignore, Mr
Circulating Levels of PD-L1 in Mesothelioma Patients from the NIBIT-MESO-1 Study: Correlation with Survival 2020 Chiarucci, C; Cannito, S; Daffinà, M G; Amato, G; Giacobini, G; Cutaia, O; Lofiego, Mf; Fazio, C;... Giannarelli, D; Danielli, R; Di Giacomo, Am; Coral, S; Calabro', L; Maio, M; Covre, A
Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC 2019 Antonia, S; Balmanoukian, A; Brahmer, J; Ou, S-H; Hellmann, M; Kim, S-W; Ahn, M-J; Kim, D-W; Guti...errez, M; Liu, S; Schöffski, P; Jäger, D; Jamal, R; Jerusalem, G; Lutzky, J; Nemunaitis, J; Calabro', L; Weiss, J; Gadgeel, S; Bhosle, J; Ascierto, P; Rebelatto, M; Narwal, R; Liang, M; Xiao, F; Antal, J; Abdullah, S; Angra, N; Gupta, Ak; Khleif, Sn; Segal, Nh
Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme 2013 Altomonte, M; Di Giacomo, A; Queirolo, P; Ascierto, P; Spagnolo, F; Bajetta, E; Calabro', L; Dani...elli, R; de Rosa, F; Maur, M; Chiarion-Sileni, V; Ferrucci, P; Giannarelli, D; Testori, A; Ridolfi, R; Maio, M.